Neidhart JA - Search Results

1

Phase I/II trial of high dose mitoxantrone in metastatic breast cancer: the M.D. Anderson Cancer Center experience.

Cristofanilli M, Holmes FA, Esparza L, Valero V, Buzdar AU, Neidhart JA, Hortobagyi GN. Cristofanilli M, et al. Among authors: neidhart ja. Breast Cancer Res Treat. 1999 Apr;54(3):225-33. doi: 10.1023/a:1006104610727. Breast Cancer Res Treat. 1999. PMID: 10445421 Clinical Trial.

2

Dose-intensive treatment of breast cancer supported by granulocyte-macrophage colony-stimulating factor (GM-CSF).

Neidhart JA. Neidhart JA. Breast Cancer Res Treat. 1991 Dec;20 Suppl:S15-23. doi: 10.1007/BF01908240. Breast Cancer Res Treat. 1991. PMID: 1687203

3

High-dose mitoxantrone in metastatic breast cancer: a phase I-II trial.

Leiby JM, Unverfurth DV, Neidhart JA. Leiby JM, et al. Among authors: neidhart ja. Cancer Treat Rep. 1986 Jul;70(7):899-901. Cancer Treat Rep. 1986. PMID: 3719583

4

Phase II pilot study with cisplatin, etoposide, and continuous-infusion 5-fluorouracil in metastatic non-small cell lung cancer.

Lee JS, Dhingra HM, Chiuten DF, Holoye PY, Jeffries D, Murphy WK, Umsawasdi T, Neidhart JA. Lee JS, et al. Among authors: neidhart ja. Am J Clin Oncol. 1987 Dec;10(6):512-4. doi: 10.1097/00000421-198712000-00010. Am J Clin Oncol. 1987. PMID: 2825509

5

Failure of GM-CSF to permit dose-escalation in an every other week dose-intensive regimen for advanced breast cancer.

Osborne CK, Sunderland MC, Neidhart JA, Ravdin PM, Abeloff MD. Osborne CK, et al. Among authors: neidhart ja. Ann Oncol. 1994 Jan;5(1):43-7. doi: 10.1093/oxfordjournals.annonc.a058689. Ann Oncol. 1994. PMID: 8172792 Free article. Clinical Trial.

6

Randomized trial of doxorubicin, bisantrene, and mitoxantrone in advanced breast cancer: a Southwest Oncology Group study.

Cowan JD, Neidhart J, McClure S, Coltman CA Jr, Gumbart C, Martino S, Hutchins LF, Stephens RL, Vaughan CB, Osborne CK. Cowan JD, et al. J Natl Cancer Inst. 1991 Aug 7;83(15):1077-84. doi: 10.1093/jnci/83.15.1077. J Natl Cancer Inst. 1991. PMID: 1875415 Clinical Trial.

7

Phase I trial of homoharringtonine.

Neidhart JA, Young DC, Derocher D, Metz EN. Neidhart JA, et al. Cancer Treat Rep. 1983 Sep;67(9):801-4. Cancer Treat Rep. 1983. PMID: 6883357

8

Hematopoietic colony-stimulating factors. Uses in combination with standard chemotherapeutic regimens and in support of dose intensification.

Neidhart JA. Neidhart JA. Cancer. 1992 Aug 15;70(4 Suppl):913-20. Cancer. 1992. PMID: 1379115 Review.

9

Phase 1 trial of recombinant human interleukin-1 beta (rhIL-1 beta), carboplatin, and etoposide in patients with solid cancers: Southwest Oncology, Group Study 8940.

Rinehart J, Hersh E, Issell B, Triozzi P, Buhles W, Neidhart J. Rinehart J, et al. Cancer Invest. 1997;15(5):403-10. doi: 10.3109/07357909709047578. Cancer Invest. 1997. PMID: 9316621 Clinical Trial.

10

Phase I trial of teroxirone.

Neidhart JA, Derocher D, Grever MR, Kraut EH, Malspeis L. Neidhart JA, et al. Cancer Treat Rep. 1984 Sep;68(9):1115-9. Cancer Treat Rep. 1984. PMID: 6478450

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters